Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,420.00    -35.00 (-0.64%)
Bid:
5,415.00
Ask:
5,420.00
Spread: 5.00 (0.092%)
Market Cap: £3.94b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Results

23 Jan 2008 07:30

Renishaw PLC23 January 2008 Renishaw plc and subsidiary undertakings 23rd January 2008 Interim results 2008Interim results for the half year ended 31st December 2007 Consolidated income statement 6 months to 6 months to December 2007 December 2006 £'000 £'000 Revenue 91,640 87,120Cost of sales (52,006) (48,128) ----------- -----------Gross profit 39,634 38,992 ----------- ----------- Distribution costs (16,540) (16,407)Administrative expenses (9,930) (10,572) ----------- -----------Operating profit 13,164 12,013 Financial income 4,437 3,978Financial expenses (2,539) (2,478) ----------- -----------Profit before tax 15,062 13,513 Income tax expense (3,012) (2,703) ----------- -----------Profit for the period 12,050 10,810 ----------- ----------- Earnings per share (basic and diluted) 16.6p 14.9pProposed dividend per share 7.76p 7.05p Consolidated statement of recognised income and expense 6 months to 6 months to December 2007 December 2006 £'000 £'000 Foreign exchange translation differences 1,117 (394) Actuarial loss in the pension schemes (1,458) (13,693)Changes in fair value of cash flow hedges (2,429) 511 Deferred tax on items recognised on income andexpense 1,236 4,014 ----------- -----------Loss recognised in equity (1,534) (9,562)Profit for the period 12,050 10,810 ----------- -----------Total recognised income and expense for theperiod 10,516 1,248 ----------- ----------- Consolidated balance sheet At December At December 2007 2006 £'000 £'000 AssetsProperty, plant and equipment 69,592 69,779Intangible assets 15,559 13,654Investments in associates 6,931 908Deferred tax assets 5,453 14,633Employee benefits 5,365 - ------------ -----------Total non-current assets 102,900 98,974 ------------ ----------- Current assetsInventories 35,100 30,995Trade receivables 38,002 32,814Current tax 557 298Other receivables 4,990 7,656Cash and cash equivalents 16,399 26,549 ------------ -----------Total current assets 95,048 98,312 ------------ ----------- Current liabilitiesTrade payables 8,979 10,926Current tax 1,985 2,177Provisions 778 891Other payables 7,209 6,463 ------------ -----------Total current liabilities 18,951 20,457 ------------ ----------- ------------ -----------Net current assets 76,097 77,855 ------------ ----------- Non-current liabilitiesEmployee benefits - 32,058Deferred tax liabilities 11,996 11,756 ------------ -----------Total non-current liabilities 11,996 43,814 ------------ ----------- ------------ -----------Total assets less total liabilities 167,001 133,015 ------------ ----------- EquityIssued capital 14,558 14,558Share premium 42 42Currency translation reserve 907 (129)Cash flow hedging reserve 96 2,365Retained earnings 151,398 116,179 ------------ -----------Total equity 167,001 133,015 ------------ ----------- Consolidated statement of cash flow 6 months to 6 months to December 2007 December 2006 £'000 £'000Cash flows from operating activitiesProfit for the period 12,050 10,810 ----------- -----------Adjustments for:Amortisation of development costs 1,642 1,052Amortisation of other intangibles 800 493Depreciation 4,033 3,765Profit on sale of fixed assets (10) (8)Share of profits from associates (160) -Financial income (4,437) (3,978)Financial expenses 2,539 2,478Tax expense 3,012 2,703 ----------- ----------- 7,419 6,505 ----------- ----------- Decrease/(increase) in inventories 1,078 (2,636)Decrease in trade and other receivables 885 2,471Decrease in trade and other payables (4,217) (2,951)Difference between pension charge andcontributions - 259Increase in provisions 85 98 ----------- ----------- (2,169) (2,759) ----------- -----------Income taxes paid (2,307) (2,018) ----------- -----------Cash flows from operating activities 14,993 12,538 ----------- ----------- Investing activitiesPurchase of tangible fixed assets (2,682) (5,902)Development costs capitalised (3,039) (2,240)Purchase of other intangibles (966) (416)Investment in associates, net of dividendreceived 21 -Sale of tangible fixed assets 75 93Interest received 721 785 ----------- -----------Cash flows from investing activities (5,870) (7,680) ----------- -----------Financing activitiesInterest paid (84) (20)Dividends paid (11,515) (10,969) ----------- -----------Cash flows from financing activities (11,599) (10,989) ----------- ----------- Net decrease in cash and cash equivalents (2,476) (6,131) Cash and cash equivalents at beginning ofperiod 20,761 30,728 Effect of exchange rate fluctuations on cashheld (1,886) 1,952 ----------- -----------Cash and cash equivalents at end of period 16,399 26,549 ----------- ----------- Revenue analysis 6 months to 6 months to First half December 2007 December 2006 revenue at previous year exchange rates £'000 £'000 £'000 Continental Europe 33,166 31,672 32,769Far East, including Japan &Australia 28,253 25,766 29,623North & South America 21,469 22,025 22,470UK and Ireland 6,248 5,232 6,248Other overseas regions 2,504 2,425 2,439 ----------- ----------- -----------Revenue 91,640 87,120 93,549 ----------- ----------- ----------- *************************NOTES: 1. The Interim report was approved by the directors on 23rd January 2008. This interim financial information has been prepared on the basis of theaccounting policies adopted in the most recent annual financial statements,these being for the year ended 30th June 2007, as revised for the implementationof specified new amended endorsed standards or interpretations. The interim financial information for the six months to 31st December 2007 andthe comparative figures for the six months to 31st December 2006 are unaudited.The comparative figures for the financial year ended 30th June 2007 are anabridged version of the statutory accounts for that financial year. Thoseaccounts have been reported on by the Company's auditors and delivered to theregistrar of companies. The report of the auditors was unqualified and did notcontain a statement under section 237(2) or (3) of the Companies Act 1985. 2.The interim dividend of 7.76p net per share for the year ended 30th June 2008 will be paid on 7th April 2008 to shareholders on the register on 7th March 2008. **************************Half year management reportChairman's statement I am pleased to report Renishaw's results for the first six months of thecurrent year ended 31st December 2007. As anticipated at the AGM last October, performance has continued to improvethroughout the first six months with revenue increasing by 5% to £91.6m (2006£87.1m). At constant exchange rates, revenue would have been £1.9m higher, anincrease of 7% reflecting good progress in our major geographic markets,particularly the Far East. Within the product mix, there was above-averagegrowth in laser and calibration, machine tool and styli products, if partlyoffset by lower revenue from spectroscopy and dental products. Operating profit rose 9.5% to £13.2m (2006 £12.0m). At constant exchange ratesthe operating profit would have increased to approximately £15.0m, an increaseof 25%. Profit before tax increased 11.4% to £15.1m (2006 £13.5m). Profit aftertax amounted to £12.1m (2006 £10.8m), resulting in earnings per share up 11.4%to 16.6p (2006 14.9p). A high level of research and development remains integral to Renishaw'sprogress; research and development, including associated engineering costs,during the period amounted to £15.6m (2006 £14.8m). During this half year wehave particularly focussed on the large number of new products recentlyintroduced. The recent and very positive response to REVO(TM) from the aerospace andautomotive sectors has reinforced our belief in the Group's current approach tothe market. In addition to new sales, the opportunity for significant growth ofthe retrofit market for REVO(TM) is currently being discussed with our OEMcustomers, with a view to maximising the market potential. Net cash balances at 31st December 2007 were £16.4m (30th June 2007 £20.8m).Policies have been revised to reduce the level of investment in Group inventory,which at 31st December 2007 stood at £35.1m (30th June 2007 £36.2m). Capitalexpenditure during the six months reduced to £2.7m (2006 £5.5m). Management is continuing to concentrate on the Group's cost base and operatingmargins. Whilst performance has improved during the first half, we still expectcontinuing and improved performance in the second half, aided by resumed ordersfrom a major Japanese customer for its own export sales, growing orders for newproducts especially the REVO(TM) and the current weakness of sterling. Theprincipal risks remain substantially the same as those referred to in lastyear's Annual report. An interim dividend of 7.76p (2007 7.05p) per share, an increase of 10%, will bepaid on 7th April 2008 to shareholders on the register on 7th March 2008. Sir David R McMurtry, CBE, RDI, CEng, FIMechE, FREngChairman & Chief Executive23rd January 2008 Enquiries: B R Taylor 01453 524445 A C G Roberts 01453 524445 Registered number: 1106260Registered office: New Mills, Wotton-under-Edge, Gloucestershire. GL12 8JRTelephone: 01453 524524 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change
12th Jul 20232:30 pmRNSVoting Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.